Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Sales Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Sales Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Net Sales Growth(%) 27.4812.771.98-5.8612.44

What is the latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS is 27.48 based on Mar2026 Consolidated results.
Year Net Sales Growth
Mar202627.48
Mar202512.77
Mar20241.98
Mar2023-5.86
Mar202212.44

How is Net Sales Growth of GLENMARK PHARMACEUTICALS Trending?

Years Net Sales Growth % Change
Mar2026 27.48
115.19
Mar2025 12.77
544.95
Mar2024 1.98
Positive
Mar2023 -5.86
Negative
Mar2022 12.44 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Net Sales Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,359.1 Cr -1% -5.8% 17.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,483.0 Cr -2% -6.1% 12.9% Stock Analytics
DIVIS LABORATORIES ₹249,248.0 Cr 3.2% 5.3% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,822.0 Cr -1.9% -2.9% 32.7% Stock Analytics
CIPLA ₹105,427.0 Cr -1.5% -4% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,492.3 Cr -2.7% 4.2% -1.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1%

-5.8%

17.2%

SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses